The global ATP assays market size is expected to reach USD 472.6 million by 2028 at a CAGR of 10.5%, according to a new report by Reports and Data. The global market growth is primarily attributed to the growing demand for advanced, high-performance ATP assays in the healthcare, pharmaceutical, biotechnology, and food beverage sectors. The increasing prevalence of life-threatening diseases like cancer, the rapid spread of severely infectious diseases, such as the COVID-19 pandemic, and the growing occurrence of water-borne and food-borne illnesses are the other significant parameters accountable for the global ATP assays market’s steady growth. Moreover, the ever-increasing need for safer drugs and food products, fast-paced adoption of food contamination testing methods across various sectors, and the rising focus on laboratory hygiene have further stimulated the market growth.

ATP (adenosine triphosphate) is the primary energy source found in living organisms, and it helps efficiently determine cell viability. ATP assays are tests that detect the viability of cells while examining the overall microbiological content and accurately detecting bacterial and microbial growth. Bioluminescent ATP assays are the most widely used ATP tests and are more efficient than other methods, owing to their simplified process, higher sensitivity, homogeneous protocol, and rapid results. ATP assays are widely used in the life sciences and pharmaceutical sectors for the assessment of drug safety. Moreover, these tests find significant application in the food beverage industry for determining food safety and hygiene. Stringent regulations for food beverage manufacturing processes have led to an augmented need for food safety testing, thereby spurring the global ATP assays market growth. Furthermore, the rising number of clinical trials and increasing research collaborations among pharmaceutical companies and research institutes and universities boost global market development.

The key market players include –

Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Merck KGaA, Promega Corporation, Danaher Corporation, Geno Technology, Inc., PerkinElmer, Inc., Abcam plc, Lonza Group, Elabscience, Hygiena, LLC, AAT Bioquest, MBL International Corporation, Abnova Corporation, BioThema AB, PromoCell GmbH, Canvax Biotech S.L., BioVision, Inc., Biotium, and Creative Bioarray.

Key Highlights of the Report -

• Based on product type, the consumables accessories segment accounted for the largest market share in 2020. It is expected to continue its dominance throughout the projected period, mainly owing to the rising adoption of advanced ATP assays in the pharmaceutical and food beverage industries.
• Among the various end-users, the pharmaceutical biotechnology companies segment is poised to acquire the highest market revenue in the coming years. The growth of this segment is attributed to the surging focus on drug safety, increased government investments in the pharmaceutical and biotechnology sectors for research purposes, and new drug development projects.
• Of the key market regions, North America emerged as the leading regional segment in the global ATP assays market in 2020, retaining the highest revenue. North America’s market is predicted to grow substantially over the estimated period due to the region’s state-of-the-art healthcare infrastructure, increasing prevalence of chronic diseases like cancer, rising occurrence of contagious diseases, and a significant spike in the number of healthcare RD activities.

For the purpose of this report, the global ATP assays market has been segmented based on product type, application, end-user, and region -
By Product Type (Revenue, USD Million; 2018-2028)

• Instruments
• Luminometers
• Spectrophotometers
• Consumables Accessories
• Reagents Kits
• Microplates
• Others

By Application (Revenue, USD Million; 2018-2028)

• Disease Testing
• Contamination Testing
• Drug Discovery Development
• Others

By End-user (Revenue, USD Million; 2018-2028)

• Pharmaceutical Biotechnology Companies
• Academic Research Institutions
• Hospitals Diagnostic Laboratories
• Food Beverage Industry
• Others

By Region (Revenue, USD Million; 2018-2028)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Rest of the Asia Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East Africa
• Saudi Arabia
• UAE
• Rest of the Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Request Customization Form - https://www.reportsanddata.com/request-customization-form/3902